Skip to main navigation
Kyverna Therapeutics Logo
  • Overview
  • News Releases
  • Events & Presentations
  • Governance
    • Governance Overview
    • Board of Directors
    • Leadership Team
    • Committee Composition
  • Financials
    • SEC Filings
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • Educational Videos

Event Details

Kyverna Conference Call - KYSA-6 Phase 2 Interim Results for Myasthenia Gravis (MG)

October 29, 2025 8:00 AM EDT

Click here for webcast

Click here for Live Teleconference

Supporting Materials

KYSA-6 Phase 2 Interim Results for Myasthenia Gravis 793.4 KB

Investor Contact

drafts InvestorRelations@kyvernatx.com
drafts Media@kyvernatx.com
phone_iphone +1 510.925.2492
© 2026 Kyverna Therapeutics

Social Media

  • LinkedIn opens in new window
  • Glassdoor opens in new window
Search Investors